OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cetuximab-conjugated PLGA nanoparticles as a prospective targeting therapeutics for non-small cell lung cancer
Leena Kumari, Iman Ehsan, Arunima Mondal, et al.
Journal of drug targeting (2023) Vol. 31, Iss. 5, pp. 521-536
Open Access | Times Cited: 13
Leena Kumari, Iman Ehsan, Arunima Mondal, et al.
Journal of drug targeting (2023) Vol. 31, Iss. 5, pp. 521-536
Open Access | Times Cited: 13
Showing 13 citing articles:
Surface Functionalization of Nanocarriers with Anti-EGFR Ligands for Cancer Active Targeting
Alessandra Spada, Sandrine Gerber‐Lemaire
Nanomaterials (2025) Vol. 15, Iss. 3, pp. 158-158
Open Access | Times Cited: 1
Alessandra Spada, Sandrine Gerber‐Lemaire
Nanomaterials (2025) Vol. 15, Iss. 3, pp. 158-158
Open Access | Times Cited: 1
AS1411 aptamer/RGD dual functionalized theranostic chitosan-PLGA nanoparticles for brain cancer treatment and imaging
Mahima Chauhan, Sonali, Saurabh Shekhar, et al.
Biomaterials Advances (2024) Vol. 160, pp. 213833-213833
Closed Access | Times Cited: 6
Mahima Chauhan, Sonali, Saurabh Shekhar, et al.
Biomaterials Advances (2024) Vol. 160, pp. 213833-213833
Closed Access | Times Cited: 6
EpCAM-targeted betulinic acid analogue nanotherapy improves therapeutic efficacy and induces anti-tumorigenic immune response in colorectal cancer tumor microenvironment
Debasmita Dutta, Ashique Al Hoque, Brahamacharry Paul, et al.
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 5
Debasmita Dutta, Ashique Al Hoque, Brahamacharry Paul, et al.
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 5
PLGA and cancer: a comprehensive patent-based review on the present state of art
Venessa Nath, Mohini Singh, Bani Kumar Jana, et al.
Pharmaceutical Patent Analyst (2025), pp. 1-15
Closed Access
Venessa Nath, Mohini Singh, Bani Kumar Jana, et al.
Pharmaceutical Patent Analyst (2025), pp. 1-15
Closed Access
Molecular insights into the antineoplastic potential of apigenin and its derivatives: paving the way for nanotherapeutic innovations
Debasmita Dutta, Ashique Al Hoque, Brahamacharry Paul, et al.
Expert Opinion on Drug Delivery (2025)
Closed Access
Debasmita Dutta, Ashique Al Hoque, Brahamacharry Paul, et al.
Expert Opinion on Drug Delivery (2025)
Closed Access
ΔPSap4#5 surface-functionalized abiraterone-loaded nanoparticle successfully inhibits carcinogen-induced prostate cancer in mice: a mechanistic investigation
Ashique Al Hoque, Debasmita Dutta, Brahamacharry Paul, et al.
Cancer Nanotechnology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Ashique Al Hoque, Debasmita Dutta, Brahamacharry Paul, et al.
Cancer Nanotechnology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Nano-engineered monoclonal antibodies expanding the newer avenues for cancer targeting
Kumar Janakiraman, Gracesuganthi Jayaraj, Vaidevi Sethuraman, et al.
Macromolecular Research (2024)
Closed Access | Times Cited: 2
Kumar Janakiraman, Gracesuganthi Jayaraj, Vaidevi Sethuraman, et al.
Macromolecular Research (2024)
Closed Access | Times Cited: 2
H-ras-targeted genetic therapy remarkably surpassed docetaxel treatment in inhibiting chemically induced hepatic tumors in rats
Alankar Mukherjee, Ramkrishna Sen, Ashique Al Hoque, et al.
Life Sciences (2024) Vol. 348, pp. 122680-122680
Closed Access | Times Cited: 1
Alankar Mukherjee, Ramkrishna Sen, Ashique Al Hoque, et al.
Life Sciences (2024) Vol. 348, pp. 122680-122680
Closed Access | Times Cited: 1
Aloe and coconut extracts mediated CuInS2 nanoparticles induce apoptosis in non-small lung cancer cells (A549)
Ranjan Kr. Giri, Anjali B. Thakkar, Sunil H. Chaki, et al.
Results in Chemistry (2024) Vol. 10, pp. 101736-101736
Open Access | Times Cited: 1
Ranjan Kr. Giri, Anjali B. Thakkar, Sunil H. Chaki, et al.
Results in Chemistry (2024) Vol. 10, pp. 101736-101736
Open Access | Times Cited: 1
AICAR-loaded and panitumumab conjugated nanoparticles downregulate the expression of PD-L1 and enhance antitumor responses against ovarian cancer through the AMPK/STAT3 axis
Manoj Kumar Baniya, Ramesh Duwa, Prabhat Shrestha, et al.
Journal of Pharmaceutical Investigation (2024)
Closed Access | Times Cited: 1
Manoj Kumar Baniya, Ramesh Duwa, Prabhat Shrestha, et al.
Journal of Pharmaceutical Investigation (2024)
Closed Access | Times Cited: 1
Aptamers: ushering in new hopes in targeted glioblastoma therapy
Debarpan Chatterjee, Srijan Bhattacharya, Leena Kumari, et al.
Journal of drug targeting (2024) Vol. 32, Iss. 9, pp. 1005-1028
Closed Access
Debarpan Chatterjee, Srijan Bhattacharya, Leena Kumari, et al.
Journal of drug targeting (2024) Vol. 32, Iss. 9, pp. 1005-1028
Closed Access
Arg-Specific serine Protease-Targeted edoxaban tosylate monohydrate-Poly (lactic-co-glycolic acid) Nanoparticles: Investigating Stuart-Prower factor targeting and intestinal distribution through Ex-Vivo fluorescent visualization
Pavazhaviji Pazhani, Jose Prakash Dharmian, Somasundaram Arumugam, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 203, pp. 114459-114459
Closed Access
Pavazhaviji Pazhani, Jose Prakash Dharmian, Somasundaram Arumugam, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 203, pp. 114459-114459
Closed Access
Nano-Drug Carriers for Chemotherapeutic Agents Delivery in Cancer Disease Treatment
Priyanca Ahlawat, Rohit Kumar, Akhilesh Kumar, et al.
(2023), pp. 69-95
Closed Access
Priyanca Ahlawat, Rohit Kumar, Akhilesh Kumar, et al.
(2023), pp. 69-95
Closed Access
